Matthieu Grollemund is a Private Equity M&A partner and a member of the Firm’s Private Capital industry group.
Triple-qualified in French, U.S., and U.K. law, Matthieu has over two decades of experience advising on complex cross-border transactions in highly regulated sectors, including technology and healthcare.
Matthieu advises LBO, Growth, VC firms, strategic players, as well as boards and special committees, on high-stakes investments, infrastructure projects, M&A transactions and both negotiated and contested acquisitions.
Education
- University of Paris I, Pantheon Sorbonne, Corporate Law
- ESCP Paris, M.B.A.
Admissions & Qualifications
- Paris
- Solicitor of England and Wales
- Licensed as a Foreign Legal Consultant, New York
Awards & Recognition
Europe Most Innovative Lawyers – Financial Times, 2022
Chambers France: “Private Equity”, since 2013
Chambers Global (France): “Corporate M&A”, 2021
Legal 500 EMEA (France): “Mergers and Acquisitions - Large to mid-market deals (above €100m)”, 2020 - 2026
The Legal 500 EMEA (France): “Venture/growth capital” - Leading partner, 2026
The Legal 500 EMEA (France): “Private Equity: LBO”, Key Lawyer, 2026
The Legal 500 EMEA (France): “Mergers & Acquisitions”, Key Lawyer, 2026
Best Lawyers in France: Mergers and Acquisitions Law / Private Equity Law/ Insolvency and Reorganization Law 2027 (recognized since 2020)
Option Droit & Affaires: “LBO transactions over 300 M EUR », 2020-2025
Languages
- English
- French
- German
Matters
Recent experience includes advising:
- Advised on numerous major French Tech transactions (Doctolib, Mirakl, Ynsect, Ledger, ManoMano, Contentsquare, Sorare, Exotec, Blablacar, Dataiku, FarFetch, Back Market, PayFit, Lydia, Criteo)*
- Advised on multiple AI, energy or Infratech deals, notably:
- Ardian on the acquisition of Akuo energy*
- Verkor on its gigafactory of €2bn*
- DataOne, Goodman and hyperscalers on +€5bn Datacenters investments*
- Advised on a number of IPO and international offerings (Planisware, AAA, Criteo, Navya, Farfetch)*
- Advised numerous tender of offers and Public M&A:
- Zimmer Biomet on Medtech*
- Medtronic on Medicrea*
- Stryker on Vexim*
- Aptar on Voluntis*
- Tencent on the acquisition of a minority interest in Ubisoft from Vivendi*
- ADM in the acquisition of Neovia from Invivo and Eurazeo for €1.4bn*
*Aforementioned matters handled at prior firm.